Medtronic (NYSE: MDT) reported Q3 EPS of $1.39, $0.03 better than the analyst estimate of $1.36. Revenue for the quarter came in at $8.29 billion versus the consensus estimate of $8.33 billion.

GUIDANCE:

Medtronic sees FY2025 EPS of $5.44-$5.50, versus the consensus of $5.45.

For earnings history and earnings-related data on Medtronic (MDT) click here.